CONFIDENTIALITY. The PARTIES undertake to use all available means to guarantee the confidentiality of the information provided for performance of the CLINICAL TRIAL and obtained during its performance, and of the personal data of the subjects signed up for them, for the purpose of complying with all the requirements provided for in the current regulations. The following information is excepted from this confidentiality undertaking: (i) which is in the public domain, (ii) which was known by the PARTIES prior to it being disclosed, or (iii) which must be disclosed under legal imperative. 7.2.
CONFIDENTIALITY. Seller shall keep confidential and not use for any purpose other than fulfilling Seller’s obligations hereunder all information, drawings, specifications, inventions, engineering notices, financial information, technical data or other data furnished by Xxxxx, including any personnel data, all of which shall be returned to Buyer upon demand or upon completion by Seller of its obligations hereunder. Seller shall not advertise or publish the fact that the Seller has contracted to furnish Buyer goods or services or use any trademarks or trade names of Buyer in Seller’s advertising or promotional materials without the written consent of the Buyer. Xxxxxx agrees not to solicit Xxxxx’x employees with which it had contact as result of the Order or agreement with Xxxxx. These provisions shall remain in full force and effect during the relationship between the parties and for a period of at least two years beyond the last date that any Goods or services are provided under any Purchase Order or sale document.
CONFIDENTIALITY. The Account Holder undertakes to respect the strictest confidentiality regarding all technical, commercial or other information to which he may become privy through the fulfilment of payment Services. This duty of confidentiality will remain in effect for the duration of the Account Holder's subscription to the payment Service and for the three (3) years following the termination of the Framework Agreement. This duty of confidentiality does not apply to information that is or may become available to the public through no fault of the Account Holder. The Parties understand that payment Transactions are covered by professional secrecy, pursuant to article L.519-22 of the Monetary and Financial Code. Lemon Way’s Website is accessible without providing any personal information. However, in order to use our services, the collection of your personal data is a condition for concluding the contract. In accordance with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to processing personal data and the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) and with Act n°78-17 of 6 January 1978 on Information Technology, data files and civil liberties, Lemon Way hereby informs you: LEMON WAY SAS, head office located at 00 xxx xx xx Xxxxxx, 00000 Xxxxxxxxx - Xxxxxx. Tel: + 00 (0) 0 00 00 00 30.
CONFIDENTIALITY. 28. PERSONAL DATA PROTECTION
CONFIDENTIALITY. All the information related to the conduct of the Clinical Trial, either before or after it, delivered or obtained, is confidential. In any event, shall the information be revealed to a third party, they shall undertake in writing to respect its confidential, secret nature in the same terms. This confidentiality agreement will remain valid indefinitely after the completion of the Contract. The Principal Investigator commits to ensure that all members of the investigation staff and any third party to whom he/she may reveal any confidential information concerning this study sign a confidentiality clause in similar terms to those provided in this contract, or their adherence to the content of this contract, prior to the start of their collaboration in this clinical trial. Finally, all the parties and collaborating staff should take all necessary actions to maintain the confidentiality of the personal data they may know as a consequence of the conduct of the trial, as established by the rules on data protection. “Rules on data protection” shall be understood as any laws, bylaws, declarations, decrees, directives, legislative enactments, orders, ordinances, regulations, rules or any other binding restrictions, as well as their amendments, consolidated versions or re-enactments, on the protection of individuals with regard to the processing of their personal data, which each party is, specifically, subject to. The Site shall endeavor to respect it and, jointly with the Principal Investigator, will restrict access to information only to those assumptions required for the correct implementation of the Protocol. In order to do so, the Principal Investigator will dissociate adequately the personal data of the subjects of the Clinical Trial and the Sponsor will not have access to such personal data. The personal data of individuals taking part in the trial, to the extent permitted by the informed consent and in the exercise of their professional duties, will be only accessed by the trial monitors and the relevant authorities. In this respect, the following shall be strictly observed: Organic Law 3/2018, of December 5, on the Protection of Personal; the Data Protection Regulation (“LOPDGDD”), as well as Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and the free circulation of this data and for which Directive 95/46 / EC is repealed (“DPR”), Law...
CONFIDENTIALITY. The Buyer shall undertake to keep in strict confidence all information obtained from the Company and shall not use any such information for any purpose other than the purposes originally intended. Buyer shall protect the confidentiality of all such information with the same degree of care it uses to protect its own confidential information, but in no event less than a reasonable standard of care. For the avoidance of doubt, the Price of the Products shall be deemed to be confidential information for the purposes of this Section 23. The Buyer agrees that it would be difficult to measure any damages caused to the Company which might result from any actual or threatened breach by the Buyer of the promises set forth in this Section 24, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly, the Buyer agrees that the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any actual or threatened breach by the Buyer of the promises set forth in this Section 23, without the necessity of proving actual damages and without the posting of any bond. Buyer
CONFIDENTIALITY. The Vendor agrees that the terms and conditions contained in this Purchase Order are confidential. Except that for any law, regulation or court of any jurisdiction, requires that the information be disclosed, or by the need of the parties in the processes of its operation, the Vendor must keep confidential all the information related to this Agreement, to keep said information safe and protected against theft, damage, loss or access not authorized to third parties and not to use said information for any purpose except for those contemplated in this Order. Likewise, the Vendor must internally implement the steps necessary to prevent the disclosure of the confidential information, including without limitation, the entry into of confidentiality agreements with its employees, officers, partners and contractors.
CONFIDENTIALITY. The Vendor, its officers, legal representatives, employees, workers, agents and/or any third party involved in the execution of the subject matter of the order, will keep in absolute secrecy and strict confidentiality all the information, know-how, plans, issues, strategies and/or operations coming from this purchase Order that are of its knowledge during the execution of it, related to Novartis and/or its affiliates, headquarters, correspondents, agencies, subsidiaries, for them not to be of the public knowledge. If Novartis requires so, the Vendor and/or its staff, agents, and or third parties related for the execution of this order, they will subscribe confidentiality commitments or agreements by writing, which could be supplied by Novartis, reason for which the Vendor warrants that will limit as much as possible, the access of the staff to confidential information.
CONFIDENTIALITY. The Supplier, including its subcontractors, employees or related third parties, are responsible to keep the strict confidentiality of any information transferred by the Purchaser or other Purchaser’s group companies, and to treat such information as a commercial and industrial secret, guaranteeing that no third party is able to access the same. The foregoing will not apply to any information which the Supplier can prove:
CONFIDENTIALITY. 6.1. Each party acknowledges and agrees that in the performance of this Agreement it may have access to or may be exposed to, directly or indirectly, confidential information of the other party ("Confidential Information"). Confidential Information includes Uber Data, Driver IDs, User Information, and the transaction volume, marketing and business plans, business, financial, technical, operational and such other non-‐public information of each party (whether disclosed in writing or verbally) that such party designates as being proprietary or confidential or of which the other party should reasonably know that it should be treated as confidential.